Provided by Tiger Fintech (Singapore) Pte. Ltd.

PDS Biotechnology Corporation

1.12
+0.01000.90%
Post-market: 1.170.0500+4.46%17:27 EDT
Volume:363.07K
Turnover:398.27K
Market Cap:51.20M
PE:-1.20
High:1.12
Open:1.10
Low:1.06
Close:1.11
Loading ...

CitiFirst Trading Warrants Issue date 25 Jul 2025 PDS-CTW

Reuters
·
24 Jul

PDS Biotechnology Announces Expansion to Stage 2 of Phase 2 Clinical Trial for PDS01ADC in Metastatic Colorectal Cancer Following Positive Initial Results

Reuters
·
10 Jul

PDS Biotechnology Price Target Maintained With a $13.00/Share by HC Wainwright & Co.

Dow Jones
·
01 Jul

PDS Biotechnology Corporation Conducted Annual Stockholders Meeting

Reuters
·
12 Jun

PDS Biotechnology Price Target Maintained With a $13.00/Share by HC Wainwright & Co.

Dow Jones
·
11 Jun

PDS Biotechnology Corporation Announces Promising Phase 3 Clinical Trial Targeting HPV16-Positive Head and Neck Cancer

Reuters
·
02 Jun

PDS Biotechnology (PDSB) Initiated with a Buy at B.Riley Financial

TIPRANKS
·
20 May

PDS Biotechnology Corp reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
14 May

PDS Biotechnology Q1 EPS $(0.21) Beats $(0.25) Estimate

Benzinga
·
14 May

PDS Biotechnology Corp expected to post a loss of 25 cents a share - Earnings Preview

Reuters
·
12 May

BRIEF-Pds Biotechnology Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
10 May

BRIEF-Pds Biotech Announces Pds01adc Clinical Data To Be Presented At The American Association For Cancer Research

Reuters
·
08 Apr

PDS Biotech Announces PDS01ADC Clinical Data to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2025

GlobeNewswire
·
08 Apr

PDS Biotechnology Corp (PDSB) Q4 2024 Earnings Call Highlights: Strategic Advances Amid ...

GuruFocus.com
·
28 Mar

Q4 2024 PDS Biotechnology Corp Earnings Call

Thomson Reuters StreetEvents
·
28 Mar

PDS Biotechnology Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
28 Mar

PDS Biotechnology Corp reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
27 Mar

PDS Biotechnology FY 2024 GAAP EPS $(1.03) Beats $(1.11) Estimate

Benzinga
·
27 Mar

Press Release: PDS Biotech Reports Full Year 2024 Financial Results and Provides Clinical Programs Update

Dow Jones
·
27 Mar

PDS Biotechnology Corp expected to post a loss of 28 cents a share - Earnings Preview

Reuters
·
25 Mar